The global burden of antimicrobial resistance - urinary tract infections

Sibylle Von Vietinghoff1, Olga Shevchuk2, Ulrich Dobrindt3

  • 1University Hospital Bonn, Medical Clinic 1, Section for Nephrology and University  Bonn, Germany.

Insights

Antimicrobial resistance (AMR) is a growing threat, especially in urinary tract infections (UTIs) caused by Gram-negative bacteria. New strategies, including antimicrobial peptides and bacteriophages, are needed to combat resistant uropathogens.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial resistance (AMR) is a critical global health issue, accelerated by antibiotic use, particularly in Gram-negative pathogens.
  • Urinary tract infections (UTIs) are frequently caused by Gram-negative bacteria, which exhibit high adaptation and possess specific virulence and AMR factors.
  • The interplay between resistance and virulence in uropathogens is complex, with beta-lactamases being a prominent AMR mechanism.

Purpose of the Study:

  • To summarize current knowledge on clinical and microbiological AMR in UTIs.
  • To discuss the factors influencing AMR prevalence in UTIs, including antibiotic consumption and urinary tract physiology.
  • To explore innovative, non-antibiotic approaches for combating uropathogenic microbes.

Main Methods:

  • Review of existing literature on antimicrobial resistance in UTIs.
  • Analysis of factors contributing to AMR emergence, such as antibiotic history and host-pathogen interactions.
  • Evaluation of alternative treatments like antimicrobial peptides and bacteriophages.

Main Results:

  • AMR in UTIs is influenced by patient populations, antibiotic history, and urinary tract conditions.
  • Uropathogens demonstrate complex mechanisms for acquiring both virulence and AMR.
  • Antimicrobial peptides and bacteriophage therapy show promise as alternatives to antibiotics.

Conclusions:

  • Addressing AMR in UTIs requires a multifaceted approach beyond traditional antibiotics.
  • Innovative strategies, including risk prediction and non-antibiotic therapies, are essential for future management of UTIs.
  • Further research into antimicrobial peptides and bacteriophages is warranted for effective treatment of resistant uropathogen infections.

Related Concept Videos

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
18
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
14
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
36
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
22
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
17
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
17